olivlawolivlaw

olivLaw · US equity research

BWX Technologies, Inc. BWXT

Engines & Turbines · SIC 3510 · Vertical: Engines & Turbines (SIC 3510)

121.50USD−7.83% · 1 dayClose 04 Nov 2026

BWX Technologies is a specialty manufacturer of nuclear components and a developer of nuclear technologies, with major customers in the U.S. Government and the civil nuclear power industry. The company reported second quarter 2026 results ahead of its expectations and raised its guidance for the year, which makes its profile relevant for those following demand for nuclear energy and defense.

The AI analysis may be outdated: new filings came after its sources (see the «AI analysis» section).

At the close of 04 Nov 2026, BWX Technologies, Inc. (BWXT) stock was 121.50 USD (−7.83% on the day), with market capitalisation 11.1 bn USD, P/E 29.8 on diluted EPS of 4.08 USD over the last 12 months, dividend yield 0.84%, beta 1.33, 52-week range 121.50–238.42 USD. Latest reported quarter (Q3 2026): revenue of 953.0 m USD (+10.0% YoY), net income of 101.7 m USD (+23.9% YoY), diluted EPS 1.11 USD.

Data as of · AI analysis dated · Source: SEC filings and closing prices, computed by olivLaw.

Market cap
11.1 bn USD
shares as of 30 Oct 2026
P/E (TTM)
29.8
Diluted EPS TTM 4.08 · TTM to 30 Sept 2026
E/P (TTM)
3.36%
TTM to 30 Sept 2026
Dividend yield
0.84%
DPS 12m 1.02
Beta (2y)
1.33
Volatility (1y) 46%
52-week range
121.50238.42

Price history

Loading chart…

Technical reading

RSI (14)
32.7
weak (30–45)
Bollinger (20, 2)
123.85 – 144.73
below the lower band · %B -0.11 · band width 15.6%
SMA 50 / 200
142.08 / 183.59
downtrend (price < SMA50 < SMA200)
MACD (12, 26, 9)
-3.92 / -3.66
MACD below signal

Indicators describe past prices; on their own they do not predict direction. On our history the RSI ≤ 40 filter added no return (see the signals methodology).

Performance

CompanyS&P 500vs S&P 500Vertical median
1 month−10.2%−1.1%−9.1 pp—
3 months−27.8%−0.5%−27.3 pp—
6 months−43.5%+4.4%−47.9 pp—
Year to date−29.7%+12.3%−42.0 pp—
1 year−39.4%+13.5%−52.9 pp−5.2%
3 years+59.6%+76.4%−16.8 pp+110.5%
5 years+120.6%+63.7%+56.9 pp—
Max drawdown (1y)
−49.0%
15 Apr 2026 → 04 Nov 2026
Max drawdown (5y)
−49.0%
15 Apr 2026 → 04 Nov 2026
Compound annual growth (5y)
+17.1%
S&P 500 +10.4%

Price returns, dividends excluded.

Quarterly results

Latest quarter: Q3 2026 · 30 Sept 2026

Revenue
953.0 m USD
+10.0% YoY
Net income
101.7 m USD
+23.9% YoY
Diluted EPS
1.11
+24.7% YoY
net / operating
10.7% / 13.9%

Quarterly margins

Quarterly statements · USD

Fiscal yearQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Revenue746.3 m682.3 m764.0 m866.3 m885.8 m860.2 m901.6 m953.0 m
Cost of revenue571.9 m517.1 m572.6 m677.3 m698.6 m662.8 m699.3 m725.8 m
Research & development2.6 m2.0 m4.6 m3.5 m3.8 m4.1 m4.2 m3.8 m
SG&A90.7 m87.6 m102.9 m93.4 m110.5 m108.0 m108.4 m117.2 m
Operating income92.3 m96.6 m102.4 m113.3 m92.1 m106.7 m114.1 m132.1 m
Depreciation & amortisation22.4 m23.9 m27.3 m ≈28.5 m ≈29.6 m29.0 m31.4 m ≈33.5 m ≈
Interest expense9.3 m8.0 m11.7 m14.0 m10.5 m4.7 m5.3 m5.1 m
Pre-tax income78.1 m91.8 m97.8 m107.6 m101.0 m107.3 m113.6 m131.9 m
Income tax7.0 m16.3 m19.3 m25.4 m7.3 m16.1 m24.5 m29.9 m
Net income71.0 m75.5 m78.4 m82.1 m93.0 m91.1 m89.0 m101.7 m
Diluted EPS0.770.820.850.891.010.990.971.11
Operating cash flow276.9 m50.7 m159.0 m ≈143.2 m ≈127.0 m92.6 m156.4 m ≈202.7 m ≈
Capex52.5 m33.4 m32.7 m ≈48.3 m ≈70.2 m42.5 m41.4 m ≈52.3 m ≈
Dividends paid22.0 m23.7 m23.1 m ≈22.9 m ≈22.8 m25.8 m24.7 m ≈24.7 m ≈
Share repurchases030.0 m0 ≈0 ≈000 ≈0 ≈

≈ derived quarter (cumulative difference / share-days average)

E/P over time

E/P = trailing-12-month diluted EPS / price at quarter end. E/P is the inverse of P/E and stays defined when earnings are negative.

Today's P/E sits at the 60 percentile of its own 40-quarter history (min 14.8, median 26.4, max 55.4; quarters with earnings only).

Fiscal years

Fiscal year20182019202020212022202320242025
Revenue1.8 bn1.9 bn2.1 bn2.1 bn2.2 bn2.5 bn2.7 bn3.2 bn
Revenue YoY+6.6%+5.3%+12.1%+0.0%+5.1%+11.8%+8.3%+18.3%
Net income227.0 m244.1 m278.7 m305.9 m238.2 m245.8 m281.9 m328.9 m
Net income YoY+53.5%+7.6%+14.2%+9.8%−22.1%+3.2%+14.7%+16.7%
Diluted EPS2.272.552.913.242.602.683.073.58
Diluted EPS YoY+54.4%+12.3%+14.1%+11.3%−19.8%+3.1%+14.6%+16.6%
net %12.6%12.9%13.1%14.4%10.7%9.8%10.4%10.3%
Free cash flow60.0 m97.2 m-58.6 m75.0 m46.4 m212.4 m254.8 m295.3 m

Reported results vs expectations

Loading…

Balance sheet & financial health

Fiscal year 2025 · 31 Dec 2025

Cash
499.8 m USD
Financial debt
2.0 bn USD
Net debt
1.5 bn USD
Equity
1.2 bn USD
Total assets
4.3 bn USD
Debt / equity
1.64x
Current ratio
2.32x
ROE
28.4%
ROA
9.2%
FCF margin
9.2%

Financial statements (source on every figure)

Revenue and net income (USD)

Margins

Income statement · USD

Revenue
2023
2.5 bn
2024
2.7 bn
2025
3.2 bn

SEC (XBRL)· 23 Feb 2026verified

Cost of revenue
2023
1.9 bn
2024
2.0 bn
2025
2.5 bn

SEC (XBRL)· 23 Feb 2026verified

Gross profit
2023
620.6 m ≈
2024
655.2 m ≈
2025
732.9 m ≈

SEC (XBRL)· 23 Feb 2026derived

Research & development
2023
7.6 m
2024
7.5 m
2025
13.9 m

SEC (XBRL)· 23 Feb 2026verified

SG&A
2023
279.7 m
2024
318.7 m
2025
394.4 m

SEC (XBRL)· 23 Feb 2026verified

Operating income
2023
383.1 m
2024
380.6 m
2025
404.5 m

SEC (XBRL)· 23 Feb 2026verified

Depreciation & amortisation
2023
78.6 m
2024
85.9 m
2025
109.2 m

SEC (XBRL)· 23 Feb 2026verified

EBITDA
2023
461.6 m ≈
2024
466.5 m ≈
2025
513.6 m ≈

SEC (XBRL)· 23 Feb 2026derived

Interest expense
2023
47.0 m
2024
39.5 m
2025
44.2 m

SEC (XBRL)· 23 Feb 2026verified

Pre-tax income
2023
321.4 m
2024
348.7 m
2025
398.1 m

SEC (XBRL)· 23 Feb 2026verified

Income tax
2023
75.1 m
2024
66.4 m
2025
68.3 m

SEC (XBRL)· 23 Feb 2026verified

Net income
2023
245.8 m
2024
281.9 m
2025
328.9 m

SEC (XBRL)· 23 Feb 2026verified

Diluted EPS
2023
2.68
2024
3.07
2025
3.58

SEC (XBRL)· 23 Feb 2026verified

Weighted average diluted shares
2023
91.9 m
2024
91.9 m
2025
91.9 m

SEC (XBRL)· 23 Feb 2026verified

Dividend per share
2023
0.92
2024
0.96
2025
0.96

SEC (XBRL)· 23 Feb 2026verified

Balance sheet · USD

Cash
2023
75.8 m
2024
74.1 m
2025
499.8 m

SEC (XBRL)· 23 Feb 2026verified

Receivables
2023
70.2 m
2024
99.1 m
2025
220.4 m

SEC (XBRL)· 23 Feb 2026verified

Inventories
2023
27.4 m
2024
40.3 m
2025
46.5 m

SEC (XBRL)· 23 Feb 2026verified

Current assets
2023
817.8 m
2024
930.0 m
2025
1.6 bn

SEC (XBRL)· 23 Feb 2026verified

Property, plant & equipment, net
2023
1.2 bn
2024
1.3 bn
2025
1.6 bn

SEC (XBRL)· 23 Feb 2026verified

Goodwill
2023
297.0 m
2024
287.4 m
2025
500.9 m

SEC (XBRL)· 23 Feb 2026verified

Intangibles (excl. goodwill)
2023
185.5 m
2024
165.3 m
2025
329.9 m

SEC (XBRL)· 23 Feb 2026verified

Total assets
2023
2.7 bn
2024
2.9 bn
2025
4.3 bn

SEC (XBRL)· 23 Feb 2026verified

Accounts payable
2023
126.7 m
2024
158.1 m
2025
141.3 m

SEC (XBRL)· 23 Feb 2026verified

Short-term debt
2023
6.3 m
2024
12.5 m
2025
0

SEC (XBRL)· 23 Feb 2026verified

Long-term debt
2023
1.2 bn
2024
1.0 bn
2025
2.0 bn

SEC (XBRL)· 23 Feb 2026verified

Current liabilities
2023
375.0 m
2024
474.2 m
2025
672.0 m

SEC (XBRL)· 23 Feb 2026verified

Total liabilities
2023
—
2024
1.8 bn
2025
3.0 bn

SEC (XBRL)· 23 Feb 2026verified

Equity
2023
933.3 m
2024
1.1 bn
2025
1.2 bn

SEC (XBRL)· 23 Feb 2026verified

Cash flow · USD

Operating cash flow
2023
363.7 m
2024
408.4 m
2025
479.8 m

SEC (XBRL)· 23 Feb 2026verified

Capex
2023
151.3 m
2024
153.6 m
2025
184.6 m

SEC (XBRL)· 23 Feb 2026verified

Free cash flow
2023
212.4 m ≈
2024
254.8 m ≈
2025
295.3 m ≈

SEC (XBRL)· 23 Feb 2026derived

Investing cash flow
2023
-155.6 m
2024
-154.6 m
2025
-742.1 m

SEC (XBRL)· 23 Feb 2026verified

Financing cash flow
2023
-169.4 m
2024
-252.8 m
2025
693.6 m

SEC (XBRL)· 23 Feb 2026verified

Dividends paid
2023
85.0 m
2024
88.3 m
2025
92.5 m

SEC (XBRL)· 23 Feb 2026verified

Share repurchases
2023
0
2024
20.0 m
2025
30.0 m

SEC (XBRL)· 23 Feb 2026verified

Computed indicators

Growth

Revenue growth (YoY)
18.3%
computed by olivLawFY 2025
Revenue CAGR 3Y
12.7%
computed by olivLawFY 2022 → FY 2025
Revenue CAGR 5Y
8.5%
computed by olivLawFY 2020 → FY 2025
EBIT growth (YoY)
6.3%
computed by olivLawFY 2025
Net income growth (YoY)
16.7%
computed by olivLawFY 2025
Net income CAGR 3Y
11.4%
computed by olivLawFY 2022 → FY 2025
Net income CAGR 5Y
3.4%
computed by olivLawFY 2020 → FY 2025
EPS growth (YoY)
16.6%
computed by olivLawFY 2025
EPS CAGR 3Y
11.3%
computed by olivLawFY 2022 → FY 2025
EPS CAGR 5Y
4.2%
computed by olivLawFY 2020 → FY 2025
FCF growth (YoY)
15.9%
computed by olivLawFY 2025

Profitability

Gross margin
22.6%
computed by olivLawTTM to 30 Sept 2026
EBITDA margin
15.8%
computed by olivLawTTM to 30 Sept 2026
EBIT margin
12.4%
computed by olivLawTTM to 30 Sept 2026
Net margin
10.4%
computed by olivLawTTM to 30 Sept 2026
FCF margin
10.3%
computed by olivLawTTM to 30 Sept 2026

Returns

ROE
28.2%
computed by olivLawTTM to 30 Sept 2026 · balance sheet at 30 Sept 2026
ROA
8.8%
computed by olivLawTTM to 30 Sept 2026 · balance sheet at 30 Sept 2026
ROIC
13.3%
computed by olivLawTTM to 30 Sept 2026 · balance sheet at 30 Sept 2026
ROCE
11.7%
computed by olivLawTTM to 30 Sept 2026 · balance sheet at 30 Sept 2026
Payout ratio (EPS)
25.0%
computed by olivLawTTM to 30 Sept 2026
Payout ratio (FCF)
26.3%
computed by olivLawTTM to 30 Sept 2026

Balance sheet

Net debt
1.5 bn USD
computed by olivLawbalance sheet at 30 Sept 2026
Net debt / EBITDA
2.6x
computed by olivLawTTM to 30 Sept 2026 · balance sheet at 30 Sept 2026
Debt / equity
1.4x
computed by olivLawbalance sheet at 30 Sept 2026
Interest coverage
17.4x
computed by olivLawTTM to 30 Sept 2026

Liquidity

Current ratio
1.9x
computed by olivLawbalance sheet at 30 Sept 2026
Quick ratio
1.8x
computed by olivLawbalance sheet at 30 Sept 2026
Cash ratio
0.6x
computed by olivLawbalance sheet at 30 Sept 2026

Cash

Operating cash flow
578.7 m USD
computed by olivLawTTM to 30 Sept 2026
Capital expenditure
206.4 m USD
computed by olivLawTTM to 30 Sept 2026
Free cash flow
372.3 m USD
computed by olivLawTTM to 30 Sept 2026
FCF conversion
99.3%
computed by olivLawTTM to 30 Sept 2026
Cash conversion
101.8%
computed by olivLawTTM to 30 Sept 2026

Efficiency

Days sales outstanding
18 days
computed by olivLawTTM to 30 Sept 2026 · balance sheet at 30 Sept 2026
Days inventory outstanding
6 days
computed by olivLawTTM to 30 Sept 2026 · balance sheet at 30 Sept 2026
Days payables outstanding
32 days
computed by olivLawTTM to 30 Sept 2026 · balance sheet at 30 Sept 2026
Cash conversion cycle
-8 days
computed by olivLawTTM to 30 Sept 2026 · balance sheet at 30 Sept 2026

Market and valuation

Market capitalisation
11.1 bn USD
computed by olivLawbalance sheet at 30 Sept 2026
Enterprise value
12.6 bn USD
computed by olivLawbalance sheet at 30 Sept 2026
Market cap / net income TTM
29.7x
computed by olivLawTTM to 30 Sept 2026
P/E (TTM)
29.8x
computed by olivLawTTM to 30 Sept 2026
Earnings yield
3.4%
computed by olivLawTTM to 30 Sept 2026
P/B
7.8x
computed by olivLawbalance sheet at 30 Sept 2026
P/S
3.1x
computed by olivLawTTM to 30 Sept 2026 · balance sheet at 30 Sept 2026
EV/EBITDA
22.1x
computed by olivLawTTM to 30 Sept 2026 · balance sheet at 30 Sept 2026
EV/EBIT
28.3x
computed by olivLawTTM to 30 Sept 2026 · balance sheet at 30 Sept 2026
EV/Sales
3.5x
computed by olivLawTTM to 30 Sept 2026 · balance sheet at 30 Sept 2026
P/FCF
29.9x
computed by olivLawTTM to 30 Sept 2026 · balance sheet at 30 Sept 2026
FCF yield
3.3%
computed by olivLawTTM to 30 Sept 2026 · balance sheet at 30 Sept 2026
Dividend yield
0.8%
computed by olivLawTTM to 30 Sept 2026
Shareholder yield (distributions)
0.9%
computed by olivLawTTM to 30 Sept 2026 · balance sheet at 30 Sept 2026

Risk

Altman Z
4.08
computed by olivLawbalance sheet at 30 Sept 2026

Valuation

olivLaw classification

Unattractive profile

Score: 59 / 100

A scoring methodology on indicators and valuation, not investment advice.

(margin_of_safety <= -0.25 & agreement in ['high', 'medium'])

Closing price

121.50 USD

04 Nov 2026Source: olivLaw, closing series

Market cap: 11.1 bn USD

Key indicators

Market capitalisation
11.1 bn USD
computed by olivLawbalance sheet at 30 Sept 2026
P/E (TTM)
29.8x
computed by olivLawTTM to 30 Sept 2026
P/B
7.8x
computed by olivLawbalance sheet at 30 Sept 2026
EV/EBITDA
22.1x
computed by olivLawTTM to 30 Sept 2026 · balance sheet at 30 Sept 2026
ROE
28.2%
computed by olivLawTTM to 30 Sept 2026 · balance sheet at 30 Sept 2026
Net margin
10.4%
computed by olivLawTTM to 30 Sept 2026
Revenue growth (YoY)
18.3%
computed by olivLawFY 2025
Dividend yield
0.8%
computed by olivLawTTM to 30 Sept 2026

Coverage and freshness

36/37 reporting lines present
Latest full fiscal year: 2025
Latest reported period: 30 Sept 2026
Latest balance sheet date: 30 Sept 2026
Share count (cover of the latest filing), as of: 30 Oct 2026
Source: SEC (XBRL)published 02 Nov 2026
verified 2785derived 194

Score by group

  • Balance sheet69
  • Growth88
  • Quality94
  • Returns48
  • Valuation12

Estimated value range

Low
39.94
USD per share
Mid
60.15
USD per share
High
84.22
USD per share
Price: 121.50 USD
The price is above the range
Potential to the central value: -50.5% (value / price − 1)
Margin of safety: -102.0% (1 − price / value)
Agreement between methods: medium · 4 methods used · 3 independent bases

The combined range = the median of the valid methods' low, central and high values; it is not a probability interval and does not cover every result. Envelope of all methods: 12.62 – 101.70 USD.

Valuation assumptions are editorial choices, not measured; beta is not measured.

Method ranges (USD per share)

— — Mid · ▏ Price

Valuation methods

  • DCF (discounted cash flow)57.56 – 101.70 (Mid 74.26)
    WACC 8.6% · starting FCFF 393.5 m USD · terminal value share of EV 76%
    The WACC × g sensitivity gives the method's bounds; these are not probabilities.
    Reverse DCF: starting growth implied by the price (fading linearly to terminal growth, everything else fixed): 33.5%
  • Peers: EV/EBITDA22.32 – 81.23 (Mid 46.03)
    4 companies used · median multiple 10.0x · quartiles 6.2x – 15.7x
    BC, CEPL, CMI, CYD
  • Peers: P/E65.96 – 87.20 (Mid 76.98)
    3 companies used · median multiple 18.9x · quartiles 16.2x – 21.4x
    CMI, CYD, PSIX
  • Dividend discount (DDM)12.62 – 16.97 (Mid 14.47)
Multiple comparisons use the SIC vertical: Engines & Turbines (SIC 3510)

Classification (SIC) comparables group by industry code, not by economic activity; the direct group is an editorial selection by activity. Members' multiples are on their own trailing twelve months, at their own latest close.

Assumptions (illustrative, editorial)

Risk-free rate
4.3%
Equity risk premium
5.0%
Beta (default)
1.00
Cost of equity
9.3%
Terminal growth
2.5%

Factor scorecard

Unattractive profile · Score 59/100

FactorValueScoreWeight used
ROIC · Quality13.3%87 (on a fixed band)10%
Net margin · Quality10.4%100 (vs peers)6%
FCF conversion · Quality99.3%99 (on a fixed band)6%
Revenue CAGR 3Y · Growth12.7%100 (on a fixed band)8%
EPS CAGR 3Y · Growth11.3%75 (on a fixed band)8%
Net debt / EBITDA · Balance sheet2.6x41 (on a fixed band)10%
Interest coverage · Balance sheet17.4x100 (on a fixed band)6%
Current ratio · Balance sheet1.9x90 (on a fixed band)4%
P/E (TTM) · Valuation29.8x1 (on a fixed band)10%
EV/EBITDA · Valuation22.1x0 (on a fixed band)10%
FCF yield · Valuation3.3%42 (on a fixed band)8%
Shareholder yield (distributions) · Returns0.9%13 (on a fixed band)6%
Payout ratio (FCF) · Returns26.3%100 (on a fixed band)4%

Score groups

  • Balance sheet69/100 · 3/3 factors with a value
  • Growth88/100 · 2/2 factors with a value
  • Quality94/100 · 3/3 factors with a value
  • Returns48/100 · 2/2 factors with a value
  • Valuation12/100 · 3/3 factors with a value

Memo

BWX TECHNOLOGIES, INC. (BWXT). Latest full fiscal year: 2025; data up to 2026-09-30.

Figures computed from the financial statements: revenue 3.2 bn USD in 2025; YoY growth 18.3%; net margin 10.4%; ROE 28.2%; net debt/EBITDA 2.6x.

The estimated value range is 39.94–84.22 USD per share (median of 4 methods, agreement: medium); assumptions are illustrative. Against the central value of 60.15 USD, the price of 121.50 USD leaves a potential of -50.5% (value / price − 1) and a margin of safety of -102.0% (1 − price / value). The range is the median of the methods' low, central and high values, not a probability interval.

olivLaw score 59/100, methodological classification: unattractive profile (score, margin of safety and method agreement together; not a judgement of the right price). Not investment advice.

Text generated deterministically from the figures shown; no language model. Not investment advice.

What supports the thesis

  • ROIC: 13.3%
  • Net margin: 10.4%
  • FCF conversion: 99.3%
  • Revenue CAGR 3Y: 12.7%
  • EPS CAGR 3Y: 11.3%
  • Interest coverage: 17.4x
  • Current ratio: 1.9x
  • Payout ratio (FCF): 26.3%

What contradicts it

  • P/E (TTM): 29.8x
  • EV/EBITDA: 22.1x
  • Shareholder yield (distributions): 0.9%
  • The price is above the estimated value range

Versus the vertical median

Engines & Turbines (SIC 3510) · same industry (4-digit SIC) · compared with 6 companies

Multiples and returns vs the median

P/E
29.8x
vertical median 18.9x
above median (+57.8%)
EV/EBITDA
22.1x
vertical median 10.0x
above median (+121.9%)
P/S
3.1x
vertical median 1.1x
above median (+170.2%)
P/B
7.8x
vertical median 3.1x
above median (+150.1%)
ROE
28.2%
vertical median 3.5%
above median (+706.0%)
Net margin
10.4%
vertical median 2.6%
above median (+304.8%)
EBIT margin
12.4%
vertical median 3.8%
above median (+228.8%)
Revenue YoY
18.3%
vertical median 3.7%
above median (+395.4%)
Net debt/EBITDA
2.6x
vertical median 0.7x
above median (+258.7%)
Dividend yield
0.8%
vertical median —

Price rebased to 100 (monthly, 5 years)

Companies in the vertical

Market capP/EROENet marginRevenue YoY1A / 3A
CMICummins Inc.65.0 bn23.923.0%8.1%−1.3%−5% / +110%
BWXTBwx Technologies, Inc.11.1 bn29.828.2%10.4%+18.3%−39% / +60%
BCBrunswick Corporation5.3 bn—-4.8%-1.5%+2.4%+23% / +3%
PSIXPower Solutions International, Inc.915.0 m13.540.1%10.0%+51.8%−27% / +1,317%
CYDChina Yuchai International Limited807.0 m18.93.5%1.7%+5.0%−40% / +136%
CEPLCapstone Energy Plus, Inc.50.4 m——3.5%+23.9%unavailable / unavailable
WPRTWestport Fuel Systems Inc.33.0 m—-59.9%-264.3%−42.7%−5% / −63%

1- and 3-year price returns: for BWXT from daily closes (the same as the performance table), for the other companies from month-end closes.

olivLaw engine forecast

The world engine ran after the company's latest material disclosure. Probabilities are of TOUCHING a level within the horizon (not closing there) and sit next to the random walk (p_rw), the no-information benchmark.

The engine has no published run for this company yet.

Valuation scenarios (editable assumptions)

Illustrative scenarios

Illustrative: not forecasts and without probabilities. Each case is one coherent set of assumptions, computed on today's figures.

Bear
Allowed range: -50 … 50%
Allowed range: -100 … 100%
Allowed range: 0 … 100
Allowed range: -10 … 20%
Allowed range: 0 … 100%
Base
Allowed range: -50 … 50%
Allowed range: -100 … 100%
Allowed range: 0 … 100
Allowed range: -10 … 20%
Allowed range: 0 … 100%
Bull
Allowed range: -50 … 50%
Allowed range: -100 … 100%
Allowed range: 0 … 100
Allowed range: -10 … 20%
Allowed range: 0 … 100%
Nothing is saved.

Estimated price (USD)

Estimated priceBearBaseBull
1 years
77.95
Total return -35% · Per year -35%
137.31
Total return 14% · Per year 14%
206.14
Total return 71% · Per year 71%
3 years
88.68
Total return -25% · Per year -9%
174.49
Total return 47% · Per year 14%
285.70
Total return 139% · Per year 34%
5 years
100.89
Total return -13% · Per year -3%
221.72
Total return 89% · Per year 14%
395.97
Total return 234% · Per year 27%
What moves the 3-year price the most
  • Exit P/E± 43.62
  • Net margin± 30.54
  • Annual revenue growth± 23.23
  • Annual dilution± 2.57

AI analysis

AI-generatedAI-generated analysis (Claude) from cited public sources; it may contain errors. Not investment advice. As of 27 Oct 2026 · Model: claude-haiku-5-5.

Possibly outdated: the newest document it read is from 03 Aug 2026; since then the company filed 8-K (02 Nov 2026 · results), 10-Q (02 Nov 2026).

In brief

BWX Technologies is a specialty manufacturer of nuclear components and a developer of nuclear technologies, with major customers in the U.S. Government and the civil nuclear power industry. The company reported second quarter 2026 results ahead of its expectations and raised its guidance for the year, which makes its profile relevant for those following demand for nuclear energy and defense 3.

SWOT

Strengths

  • The company holds a consolidated position in nuclear components for the U.S. naval fleet, with high entry barriers 1.
  • A high and growing backlog gives visibility over future revenue for several years 1.
  • The commercial segment showed solid growth in the second quarter of 2026, supported by acquisitions and services 3.

Weaknesses

  • Heavy reliance on government contracts makes revenue sensitive to budgets and congressional funding 1.
  • Fixed-price contracts can produce losses if actual costs exceed estimates 1.
  • Commercial activity depends on outage timing, so results can fluctuate from quarter to quarter 1.

Opportunities

  • The sale of the medical business could allow resources to focus on defense and civil nuclear power 3.
  • The Precision Components Group acquisition could expand the U.S. footprint in commercial nuclear component manufacturing 3.
  • If demand for new reactors and nuclear solutions grows, the company could leverage its advanced design work 1.

Threats

  • Federal budget cuts or delays could postpone contracts and payments 1.
  • Tariffs and trade restrictions could raise product costs and reduce competitiveness 1.
  • Competition for refurbishment and life-extension contracts could slow demand in Canada 1.

Risks

  • Dependence on government fundinghigh

    Government contracts make up a major part of revenue, and funding can be delayed or reduced 1.

  • Shutdowns and continuing resolutionsmedium

    Budget delays can postpone new awards and affect programs in progress 1.

  • Fixed-price contractsmedium

    Unforeseen costs can reduce profitability or produce losses on large projects 1.

  • Tariffs and Canadian exposuremedium

    Trade measures could raise costs and limit sales to U.S. customers 1.

  • Operational and security riskslow

    Cyber threats and other disruptions could affect production and contracts 1.

Investment thesis

What would need to be true (bull case)

  • If naval programs and demand for nuclear energy remain funded, the high backlog could support revenue over several years 13.
  • Recent acquisitions and a focus on core segments could improve margins and cash flow in the commercial segment 3.
  • The raised 2026 guidance shows that first-half execution ran ahead of expectations, if the trend continues 3.

What would break the thesis

  • Dependence on the federal budget could make revenue sensitive to delays and funding cuts 1.
  • Fixed-price contracts and execution risks could reduce profitability if costs rise above estimates 1.
  • Tariffs and trade uncertainty with Canada could pressure margins and competitiveness 1.

What to watch

  • Revenue and adjusted EBITDA trend against the raised guidanceQ3 2026
  • Integration of Precision Components Group and its contribution to revenue2026
  • Timing of the completion of the medical business sale2026
  • Status of the federal budget and upcoming continuing resolutions or shutdown risk2027

Products, market & competition

AI-generatedAI-generated analysis (Claude) from cited public sources; it may contain errors. Not investment advice. As of 27 Oct 2026 · Model: claude-haiku-5-5.

Possibly outdated: the newest document it read is from 03 Aug 2026; since then the company filed 8-K (02 Nov 2026 · results), 10-Q (02 Nov 2026).

The business

The company reports two segments: Government Operations and Commercial Operations 1. It has expanded through acquisitions, including Aerojet Ordnance Tennessee, completed January 3, 2025 and reported in Government Operations, and Kinectrics, completed May 20, 2025 and reported in Commercial Operations 1. In the second quarter of 2026, management announced the sale of its medical business and closed the acquisition of Precision Components Group on July 1, 2026 3.

Market context

The market BWX Technologies serves is shaped by capital-intensive nuclear industries, large contracts and high entry barriers, including the technical and regulatory requirements for nuclear components 1. The company relies heavily on public funding for defense and energy, so the market depends on budget cycles and congressional appropriations 1. Civil demand for nuclear energy and medical isotopes complements this base but remains sensitive to the economy and energy policy 1.

Guidance for 2026 was raised to revenue of about 3,800 million dollars and adjusted EBITDA between 662 and 672 million dollars 3. Management links this revision to first-half performance and the contribution of Precision Components Group 3. The company notes that demand and results can vary materially with government funding, economic conditions and contracts in progress 1.

Trends

  • Demand for nuclear energytailwind

    Management says demand for new nuclear solutions is remarkably deep and broad, which could support growth in the commercial segment 3. If investment in nuclear capacity continues, the company could benefit from larger orders for components and services.

  • U.S. budget uncertaintyheadwind

    The company warns that continuing resolutions, the debt ceiling and possible government shutdowns can delay new awards or payments 1. It notes that federal spending reductions could affect government programs and suppliers 1.

  • Tariffs and trade with Canadamixed

    Canadian operations are important, and tariffs or trade measures could raise costs and reduce product competitiveness 1. They could also weigh on margins if costs cannot be passed on to customers.

Competitive position

In the government segment, competition is limited by technical, regulatory and security requirements, and the main bases of competition are experience, past performance and technical capabilities 1. Competitors named in the report include engineering and contracting firms working on government contracts and federal sites 1.

In the commercial segment, contracts are usually awarded through competitive bidding, where price, equipment availability and reputation matter 1. The company relies on its heavy component manufacturing capacity in North America and on lifecycle services for nuclear plants 1.

  • Bechtel National, Inc.

    Competitor in delivering goods and services to the government and operating federal facilities 1.

  • Amentum Environment & Energy, Inc.

    Competitor in operating government facilities and environmental remediation for federal nuclear sites 1.

  • Fluor CorporationFLR

    Competitor in government contracts and in operating facilities for the U.S. Government 1.

  • Westinghouse Electric Corporation

    Competitor in the nuclear field, named among the company's principal competitors 1.

News & filings

In the press

The latest news item in our archive is from 22 Sept 2026; the newest SEC filing is from 04 Nov 2026. The press archive comes from the RSS feeds we follow and does not necessarily cover the latest event — the filings alongside do.

SEC filings

Sources

  1. [1] Form 10-K, fiscal year ended 2025-12-31 · SEC / BWX Technologies, Inc. · 23 Feb 2026
  2. [2] Form 10-Q, quarter ended 2026-06-30 · SEC / BWX Technologies, Inc. · 03 Aug 2026
  3. [3] Form 8-K, results release (exhibit 99.1) · SEC / BWX Technologies, Inc. · 03 Aug 2026

Figures computed by olivLaw from SEC filings and closing prices; the qualitative analysis is AI-generated from cited sources. Not investment advice.